Pricing Log in Create free account

Biomea Fusion, Inc. (BMEA) vs Caribou Biosciences, Inc. (CRBU)

Biomea Fusion, Inc. and Caribou Biosciences, Inc. are both Biotechnology companies. Biomea Fusion, Inc. and Caribou Biosciences, Inc. are of similar size ($44.2M and $42.6M). Biomea Fusion, Inc. has the higher net margin (0.00% vs −1,085.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Biomea Fusion, Inc. leads on 8 and Caribou Biosciences, Inc. on 4.

Valuation

Metric BMEA CRBU Biotechnology median
P/E n/m n/m 10.60
P/S n/m 5.01 9.40
P/B 3.34 0.62 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.45 0.66
EV/Sales n/m (5.03) 9.02
Earnings yield (88.54%) (234.09%) (32.88%)
Free cash flow yield (115.76%) (275.02%) (23.13%)

Profitability

Metric BMEA CRBU Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (1,140.55%) 0.00%
Net margin 0.00% (1,085.00%) 0.00%
Free cash flow margin 0.00% (985.95%) 0.00%
Return on equity (164.14%) (93.80%) (51.96%)
Return on assets (59.14%) (64.44%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BMEA CRBU Biotechnology median
Revenue growth (TTM) — 1.60% 6.76%
EPS growth (last fiscal year) 69.19% 3.64% 29.88%
Revenue growth, 5-year CAGR — (2.03%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BMEA CRBU Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.48 4.97 4.97
Net debt to EBITDA 0.68 0.96 1.01

Dividend

Metric BMEA CRBU Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BMEA CRBU Biotechnology median
Market cap 42.57m 44.20m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack